drugset / Trial / NCT01723579
Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017)
NaSingle-groupOpen-labelTreatment
Summary
This study will investigate the efficacy and safety of the monophasic combined oral contraceptive (COC) containing 2.5 mg NOMAC and 1.5 mg E2 in healthy fertile Indian women.
Timeline
- Start
- 2013-07
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 1.5 mg | Oral |
| Subject | Nomegestrol Acetate | Small molecule | 2.5 mg | Oral |
Indications
No indication recorded.